Clinical Trial: Seroquel XR in the Long Term Treatment of Schizophrenia
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Seroquel XR in the Long Term Treatment of Schizophrenia Focus on Affective Symptoms
Brief Summary: The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improves the relapse prevention in schizophrenic outpatients
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome:
- Rate of patients remained relapse free after 6 months of treatment [ Time Frame: on the 60th day of treatment ]
- Rate of patients remained relapse free after 6 months of treatment [ Time Frame: on the 180th day of treatment ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- connection between relapse and affective symptoms [ Time Frame: on the 60th day of treatment ]
- connection between relapse and affective symptoms [ Time Frame: 180th day of treatment ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: September 14, 2010
Date Started: September 2010
Date Completion:
Last Updated: October 21, 2011
Last Verified: October 2011